Jing-Ke Weng received his B.S. (2003) in Biotechnology from Zhejiang University, Hangzhou, China. He received his Ph.D. (2009) in Biochemistry from Purdue University, and was a pioneer postdoctoral fellow at the Salk Institute for Biological Studies and Howard Hughes Medical Institute between 2009 and 2013. Currently, he is a member of the Whitehead Institute for Biomedical Research, and an Associate Professor of Biology at Massachusetts Institute of Technology. Dr. Weng's research focuses on plant metabolic evolution, synthetic biology, and drug discovery. He is a co-Founder of DoubleRainbow Biosciences, a biotech company dedicated to developing new drugs using transformative synthetic biology and artificial intelligence approaches. Dr. Weng has won numerous awards in his career, including Smith Family Foundation Odyssey Award (2018), Scialog Fellow (2018), Beckman Young Investigator Award (2016), Alfred P. Sloan Research Fellow (2016), Searle Scholar (2015), Pew Scholar in the Biomedical Sciences (2014), American Society of Plant Biologists Early Career Award (2014), and Tansley Medal for Excellence in Plant Science (2013).